ACM Research CFO sells 55K shares after option exercise
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ACM Research, Inc. (ACMR) reported that Chief Financial Officer and Treasurer Mark McKechnie exercised stock options for a total of 55,199 shares of Class A Common Stock on August 20, 2026, at exercise prices of $19.49 and $13.89 per share, from fully vested options. He then sold 55,199 shares in three transactions at weighted-average prices of $76.34, $77.45, and $77.89 per share, with the sales effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F5 | 30,199 | $0.00 | $0.00 |
| Exercise | Stock Option F5 | 25,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 30,199 | $19.49 | $589K |
| Exercise | Class A Common Stock | 25,000 | $13.89 | $347K |
| Sale | Class A Common Stock F1, F2 | 13,625 | $76.34 | $1.04M |
| Sale | Class A Common Stock F1, F3 | 30,365 | $77.45 | $2.35M |
| Sale | Class A Common Stock F1, F4 | 11,209 | $77.89 | $873K |
Footnotes (5)
- F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.76 to $76.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), and (4) to this Form 4.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.81 to $77.79, inclusive.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.84 to $78.4, inclusive.
- F5. The option is fully vested and exercisable.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Class A Common Stock financial
Stock Option financial
fully vested and exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did ACMR’s CFO report on August 20, 2026?
What option grants did the ACMR CFO exercise in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.